Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Home>Business Resources>Business Operations>Labs/Testing

ChromaDex Announces Top Line Results of its Second Human Clinical Trial

TAGS: Healthy Living Ingredients Business Resources
<p>ChromaDex Corp. (NASDAQ:CDXC announced today that the initial results of its second human clinical study of NIAGEN<sup>&reg;</sup> nicotinamide riboside chloride (NR) have confirmed NR significantly and sustainably raises the co-enzyme nicotinamide adenine dinucleotide (NAD+) in 140 healthy human volunteers over 8-weeks.</p>
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
hempseeds
Hemp seed genetics can solve the 1% THC problem
Jan 19, 2021
Tips for brands CBD and hemp suppliers.jpg
Tips for brands: Questions to ask CBD and hemp suppliers
Dec 07, 2020
Harvesting a quality hemp supplier fromthe chaff.jpg
Harvesting a quality hemp supplier from the chaff
Nov 25, 2020
CBD supply chain considerations for product manufacturers.jpg
CBD supply chain considerations for product manufacturers
Nov 17, 2020